ABSTRACT
Since 2005, the annual number of laboratory tests performed in Calgary and south-central Alberta has increased considerably beyond the rate of population growth, a rate that threatens to be unsustainable. 1 This phenomenon is neither recent nor unique to the Calgary region and has been noted repeatedly in the literature. 2, 3 Initiatives such as Choosing Wisely [4] [5] [6] [7] have sought to reduce unnecessary testing to facilitate more clinically beneficial use of resources. Separately, regulatory directives have reiterated that increased test efficiency also constitutes practice efficiency: physicians have a duty to follow up on test results and initiate appropriate care. 8, 9 Several authors have outlined approaches to assessing the outcome of initiatives for more efficient laboratory resource utilization, [10] [11] [12] and preliminary quantifications of outcome have been published regarding the Choosing Wisely campaign in the Upon completion of this activity you will be able to:
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AJCP / Original article United States and Canada. 13, 14 Here we present the mean abnormal result rate (MARR) as a measure of changing laboratory test selectivity in Calgary and south-central Alberta from 2010 to 2015, inclusive.
A previous study set forward the MARR as a secondary utilization metric of relevance to feedback or auditing of physician practice. 15 The MARR is defined as the quotient of the count of abnormal test results divided by the count of all tests ordered. The MARR presupposes that appropriate physician selectivity in test ordering yields abnormal results at a higher rate than would be expected for random tests on healthy subjects. Analytes with reference ranges set to include the central 95% interpercentile range of values from healthy participants would therefore yield a MARR of 5% for nonselective testing of healthy participants. 16, 17 Higher MARRs suggest greater testing selectivity; a MARR of 7.5% suggests that (7.5 -5.0)/7.5 = 33% of the abnormal results represent true-positive results and possible disease, and 5.0/7.5 = 67% of the abnormal results represent false-positive results arising from how reference ranges are set. The purpose of the study was to examine patterns of change in family physician test-ordering practices over time in a large Canadian city. We hypothesized that increasing test selectivity would appear as a gradual upward trend in MARR from 2010 to 2015, as laboratory utilization management initiatives and regulatory authority directives gained prominence.
Materials and Methods
Data from 2010 to 2015 inclusive from the Laboratory Information System of Calgary Laboratory Services were examined to discern evolving changes in MARR. The catchment population encompassed roughly 1.8 million people in Calgary, Canada, and surrounding areas. As in a previous MARR proof-of-concept study, 15 this study also included analytes with a reference range that could be defined to include 95% of healthy individuals. To examine change in MARR over time, analytes included for analysis were required to be free of confounds such as substantive change in clinical practice recommendations or requisition accessibility from 2010 to 2015. Explicit criteria for including laboratory analytes are given in ❚Table 1❚; a total of 39 analytes met these criteria, as listed in ❚Table 2❚.
Only results for a patient's first test requisition for the year were included, to avoid spurious replication of substantially similar testing decisions. Only requisitions submitted by family physicians for patients in the community, not in the hospital, were included, as the minimum expected MARR of 5% draws on the statistical and regulatory norm of laboratory reference intervals defined relative to healthy individuals. 17, 18 MARRs were calculated for each year for all analytes in aggregate. These MARRs were subjected as nominal data to a Pearson χ 2 test to find a nonrandom signal and then subjected as ordinal data to a linear-by-linear 
Results
During the 6-year study period from 2010 to 2015 inclusive, family physicians in Calgary and the surrounding area ordered 20,409,316 tests on the 39 analytes meeting the study inclusion criteria for 2,467,767 patient encounters in the community, using only the first requisition in the calendar year for a given patient. Of these tests, 
Discussion
Our hypothesis was that increasing awareness by physicians of high-yield testing (eg, from initiatives such as Choosing Wisely) would manifest as increasing MARRs. This study demonstrated that the MARR in Calgary and surrounding area had a significant increase in a linear trend over time from 2010 to 2015. Numerous initiatives have promoted increased testing selectivity in the physician group analyzed in this study, 19, 20 including Choosing Wisely initiatives in the United States and Canada, 4,5 the Toward Optimized Practice initiative in Alberta, 21 and targeted education initiatives. 22 This study reported a consistent yearover-year increase during a 6-year period in MARR on outpatient tests ordered by Calgary-area family physicians, suggesting a prolonged, steady increase in test selectivity. Since 100% of laboratory tests ordered by family physicians for community patients in the Calgary zone were processed by Calgary Laboratory Services, we believe that the year-toyear MARR comparisons are valid in this study.
The change in MARR from 2010 to 2015 offers good news regarding physician test requisition selectivity. Previous studies have suggested stable or even decreasing physician test selectivity, 3, 13 with instances of increased test selectivity occurring after specific interventions targeting particular tests. 19, 20 Here, the MARR's sustained increase across a broad range of analytes suggests a more generalized increase in family physician test selectivity.
This data also demonstrate the potential usefulness of the MARR as a secondary utilization metric. The MARR does not require chart review and result abstraction by proficient individuals. The MARR provides useful information for incremental change over time if potentially confounding variables are held relatively constant (eg, scope of practice of ordering physicians, patient demographics, and the percentage of healthy individuals captured by laboratory reference intervals).
This study has limitations. The selection of analytes for inclusion used criteria that afforded a rigorous search for changes in test selectivity; the criteria did not focus on specific Choosing Wisely recommendations. From 2010 to 2015, multiple initiatives drawing on both best practices and regulatory requirements sought to increase physician test selectivity, often with overlapping provincial, national, or international scope. This observational study, however, cannot support attribution of outcome to any specific individual or group of interventions.
In addition, we are unable to determine exactly how the family physician test-ordering practices changed over Recently, we also introduced a program for family medicine residents at the University of Calgary, where pathologists and family physicians raised awareness concerning effective laboratory test-ordering practices. 22 With these demographic changes, local initiatives, and the implementation of Choosing Wisely in Canada, 5 we are unable to speculate as to the exact driver of the year-to-year changes in MARR for family physicians in Calgary.
Finally, another limitation to this study is that we do not have direct data on the rate of specialist consultations by individual family physicians during our study period. We cannot distinguish between laboratory tests ordered on a family physician's initiative and those ordered on the recommendation of a specialist consultant. However, there was an increase in numbers for both family physicians (38.6%) and specialists (30.1%) from 2010 to 2015 in the Calgary zone. 23, 24 Since the percentage increase in specialists was not greater than the increase in family physicians, laboratory tests ordered on the recommendation of specialist consultants should not have confounded the MARR in our study.
The increase in MARR we observed needs to be validated in the data of other laboratory and health care systems before an overall trend can be posited. MARRs in different jurisdictions should be directly compared only if physician practices and patient demographics are directly comparable.
Conclusions
This is good news regarding improved physician test selectivity. The MARR for Calgary and surrounding area gives preliminary evidence of a gradual increase in physician test selectivity and resource use efficiency from 2010 to 2015. Further data from other jurisdictions are needed before making assertions about broader trends in physician awareness of laboratory resource use.
